2016 Attendee remarks from Faculty and Delegates:
“You can rely on the HEART UK meeting to provide you with the most recent and up-to-date information in the field of clinical Lipidology in the UK and an insight into what is on the horizon.”
“The conference allowed me to present a poster to an audience of experts in the field of lipidology… it was a fantastic learning opportunity.”
“All of it. It is the best source of reliable information on lipid medicine and provides excellent opportunities to network and understand what's happening all over the country.”
“A good opportunity to update knowledge in the field of Lipidology and learn about things that could be applicable at the Clinic and are not just at a research level.”
“Very informative, excellent networking opportunities, suitable for clinicians, nurses and AHP's.”
“Probably best UK event for CPD in lipidology and related fields.”
"Having only been in post as British Heart Foundation Clinical Nurse Specialist in Familial Hypercholesterolaemia (FH) a couple of months, the prospect of attending a conference whereby experts in the field of lipidology, cardiology and FH are abundant was both daunting and exciting. I hoped to put names to faces, to gain a better understanding of the ‘bigger picture’ and to meet people who could stimulate my mind and trigger ideas. I am glad to say all those targets were exceeded but, not only that, the main heartfelt theme that all delegates, speakers and patients together had the same passion for the prevention of Coronary Heart Disease (CHD) was very evident. From professors to patients’, the message was clear, learning from each other and challenging practice for a better life for all, a message which was quite refreshing."
"...the HEART UK Conference taught me that everyone in the field is approachable, we all have the same aim and I look forward to the next conference where I hope to gain a better understanding of the genetics and science behind FH."
Primary & Health Care Programme
Thursday 6 - Friday 7 July 2017
Featuring educational presentations and mini sessions held in parallel to the medical and scientific programme comprising set presentations, oral abstracts and open discussion.
This section targets an audience of primary care individuals such as allied health professionals, GPs, nurses and dietitians and other health professionals with an interest in cholesterol conditions.
British Dietetic Association: BDA endorsement approved applicable only to the educational content of the learning activity.
CPD approved: Approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for category 1 (external) CPD credit(s)
Thursday x 6 credits
Friday x 4 credits
The conference is sponsored by various organisations. These organisations have had no input into the development of the programme for the study day, Medical & Scientific and Healthcare programme’s, or influenced the choice of speakers. But excluding the sponsored symposia sessions where the programme is developed and speakers identified by the sponsor. A full sponsors list can be found:
PROGRAMME – Thursday 6 July
08:00 Registration opens
08:30–09:15 Refreshments, networking and exhibition
SESSION A: Familial Hypercholesterolaemia (FH)
Mr Ray EDWARDS, Chairman, HEART UK
Dr Alan REES, Medical Director, HEART UK
Improving outcomes through personalised medicine
Ms Fiona CARRAGHER
Deputy Chief Scientific Officer, NHS England, London
Update on FH – the national view
Professor Huon GRAY
National Clinical Director for Heart Disease, NHS England
Consultant Cardiologist, University Hospital of Southampton
Child screening for FH
Professor David WALD
Professor of Cardiology
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
10:35 – 10:55
Paediatrics – a picture of inherited dyslipidaemias
Dr Uma RAMASWAMI
Consultant in Inherited Metabolic Disorders, Royal Free Hospital, London
11:00-11:30 Refreshments, networking and exhibition
Session C runs in parallel to Session B in the Medical & Scientific Programme
Hospital PCSK9 initiation - implications for primary care
Professor Elizabeth HUGHES
Director of Education and Quality HEE (London and South East); West Midlands Regional Postgraduate Dean, Birmingham, UK
Behavioural insights into getting people moving more
Mr Tim CHADBORN
Adult Health & Wellbeing Team, Health and Wellbeing Directorate, Public Health England
Diabetic Dyslipidaemia – implications for primary care
Dr Stephen LAWRENCE
GP Principal, GPSI Diabetes, St Marys Island Surgery, Chatham Kent, UK
13:15-14:30 Lunch, networking and exhibition
Primary Care workshop:
"Lipid Lowering for Primary Care – facilitating behaviour change"
Chair: Dr Arun GUPTA - GP
This participatory session is aimed at helping GP’s, Practices Nurses, and other primary care workers, involved in the management of patients with unhealthy patterns of blood lipids largely attributable to their behaviours.
Starting with a short video we will explore practical approaches to dealing with the mind processes we, as health professionals, might go through in managing dyslipidaemia, and the messages we should give (in the limited time we have available) that would influence and change behaviours.
Hear and learn about the practical aspects of understanding ourselves as healthcare advocates, and have a better understanding of what our patients might be thinking when we talk with them.
Our contributors to this session are working and dealing with behaviour change on a daily basis. Learn from a patient, Pharmacist, Nurse Practitioner and GP about how they tackle the day to day challenges.
Participation will be encouraged!
Cleo BUTTERWORTH – Governance Pharmacist
Beverley BOSTOCK – Nurse Practitioner
Sonya BRENNAN – Patient
HEART UK walk
Everyone welcome - come and enjoy this heart healthy exercise
16:00–16:45 Refreshments, networking and exhibition
Chair: Ray EDWARDS, Chairman, HEART UK
HEART UK charity update
Miss Jules PAYNE
Chief Executive, HEART UK
Cholesterol and cardiovascular disease – is diet really relevant?
Professor Tom SANDERS
This lecture will address the importance of reducing the intake of saturated and trans fatty acids for management of LDL cholesterol and what they should be replaced with in the diet in terms of type of unsaturated fatty acids carbohydrates. It will also explain how excess fat accumulation even in the normal weight ranges has adverse effects on lipids and how insulin resistance results in the atherogenic lipoprotein phenotype. It will conclude by discussing current dietary advice for the prevention of CHD and some recent controversies.
18:00 – 18:30
HEART UK AGM
Pre dinner drinks
Conference dinner and dancing
PROGRAMME – Friday 7 July
08:45 – 09:45
Moderated Poster Session
Your chance to vote for your "People's Choice" best poster
09.45 – 09:50
Dr Alan REES, Medical Director, HEART UK
Professor Gary FROST
Imperial College, London, UK
10:35 – 10:50 Discussion
10:50 - 11:20 Refreshments, networking and exhibition
Session G runs in parallel to Session F in the Medical & Scientific programme
Session sponsored by:
The psychology of food choice
Professor Jane OGDEN
Professor in Health Psychology
Department of Psychology, University of Surrey, Guildford, UK
Confronting Mixed Messages from the Media
Dr Hilary JONES
GP & Health Editor ITV Good Morning Britain
Session I runs in parallel to the Session H in the Medical & Scientific Programme
Health & Primary Care Abstracts of Free Communications
13:20 – 13:30
4/ Coronary heart disease mortality in treated familial hypercholesterolaemia : update of the UK Simon Broome FH register
Humphries SE 1*, Cooper JA1, Seed M 2, Capps N 3, Durrington PN 4, Jones, B 5, McDowell IFW 6, Soran H 7, Neil HAW 8 on behalf of the Simon Broome Familial Hyperlipidaemia Register Group
1Cardiovascular Genetics, ICS, UCL, London, 2Cardiology, Imperial College Faculty of Medicine, Charing Cross Hospital, U of London; 3Clinical Biochemistry, Princess Royal Hospital, Telford; 4Cardiovascular Research Group, U of Manchester; 5 Investigative Medicine, Imperial College London, 6Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff; 7Central Manchester University Hospitals NHS Foundation Trust, Manchester; 8Wolfson College, University of Oxford
13:30 – 13:35 Discussion
13:35 – 13:45
5/ Genetic testing for familial hypercholesterolaemia in the genomic era. The utility of an NGS test for monogenic and polygenic hypercholesterolaemia
Watson E*1, Honeychurch J1, Hills A1, Dean P1, Yarram-Smith L1, Woodward G1, Wadsley M1, Moore R1, Humphries S2, Bayly G3, Williams M1
1 Bristol Genetics Laboratory, Bristol, UK
2 Centre for Cardiovascular Genetics, UCL, London, UK
3 Department of Biochemistry, Bristol Royal Infirmary, UK
13:45 – 13:50 Discussion
13:50 – 14:00
6/ A comparison of scoring criteria for the prediction of mutations for familial hypercholesterolaemia (FH) in a cohort of Welsh lipid index patients and family relatives
Ralph A*, Ashfield-Watt PA, Haralambos K, Datta,D, McDowell IFW
School of Medicine, Cardiff University, Cardiff, CF14 4XN
14:00 – 14:05 Discussion
14:05 – 14:15
7/ Sensitivity and specificity of biochemical screening for familial hypercholesterolaemia in childhood: avon longitudinal study of parents and children (ALSPAC)
Humphries SE1*, Futema M1, Cooper JA1, Charakida M2, Boustred C3, Sattar N4, Deanfield J2, Lawlor DA5,6, Timpson NJ5,6, Hingorani AD9
1 Cardiovascular Genetics, ICS, UCL London,2 NICOR, London,3 NET Regional Genetics Service, GOSH, London, 4 Institute of Cardiovascular and Medical Sciences, Glasgow, 5 MRC Integrative Epidemiology Unit and 6 School of Social and Community Medicine, U of Bristol, 9 Genetic Epidemiology Group, ICS, UCL, London, UK
14:15 – 14:20 Discussion
14:20-14:30 Comfort break
Presentation of prizes and awards
Sanofi have sponsored this session as part of their premium sponsorship. They have had no input into the content, the speaker selection or topic selection.
Current treatments – that’s cholesterol sorted then !
THE CHARGE: Despite new treatments where will be patients who remain at significantly high cardiovascular risk.
Judge: Professor Elizabeth HUGHES, Birmingham
15:40 Conference close